Index Constituent Change - SYGH
SYGNIA ITRIX COLLECTIVE INVESTMENT SCHEME
Sygnia Itrix Solactive Healthcare 150 ETF
JSE Code: SYGH
ISIN: ZAE000300521
A portfolio in the Sygnia Itrix Collective Investment Scheme in
Securities, registered as such in terms of the Collective Investment
Schemes Control Act, 45 of 2002.
INDEX CONSTITUENT CHANGE - SYGH
In terms of section 19.28 of the JSE Limited Listings Requirements,
notice is hereby given to investors of the above ETF securities that
the following changes in the constituents of the underlying index in
the table below is effective from 03 November 2022.
The following constituents have been added to SYGH:
Share Name Previous New Weight
ISIN Weight
US03753U1060 APELLIS PHARMACEUTICALS INC 0.00% 0.08%
US4622221004 IONIS PHARMACEUTICALS INC 0.00% 0.09%
US48576A1007 KARUNA THERAPEUTICS INC 0.00% 0.08%
US5165441032 LANTHEUS HOLDINGS INC 0.00% 0.07%
JP3869010003 MATSUKIYOCOCOKARA & CO 0.00% 0.06%
US68404L2016 OPTION CARE HEALTH INC 0.00% 0.07%
The following constituents have been removed to SYGH:
Share Name Previous New Weight
ISIN Weight
GB0009633180 DECHRA PHARMACEUTICALS PLC 0.05% 0.00%
FR0014000MR3 EUROFINS SCIENTIFIC SE 0.12% 0.00%
SE0000202624 GETINGE AB CLASS B 0.06% 0.00%
ES0171996087 GRIFOLS SA CLASS A 0.04% 0.00%
IE0005711209 ICON PLC 0.22% 0.00%
VGG1110E1079 NEW BIOHAVEN 0.01% 0.00%
US87918A1051 TELADOC HEALTH INC 0.06% 0.00%
The above gave affect to changes in the index constituent weights.
The portfolio composition file can be viewed at www.sygnia.co.za/etfs/etf-and-etn-fund-range.
03 November 2022
Manager
Sygnia Itrix (RF) Pty Limited
JSE Sponsor
Vunani
Date: 03-11-2022 11:20:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.